Michael M. Witte

2.6k total citations
45 papers, 1.5k citations indexed

About

Michael M. Witte is a scholar working on Psychiatry and Mental health, Oncology and Molecular Biology. According to data from OpenAlex, Michael M. Witte has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Michael M. Witte's work include Dementia and Cognitive Impairment Research (11 papers), Alzheimer's disease research and treatments (8 papers) and Schizophrenia research and treatment (7 papers). Michael M. Witte is often cited by papers focused on Dementia and Cognitive Impairment Research (11 papers), Alzheimer's disease research and treatments (8 papers) and Schizophrenia research and treatment (7 papers). Michael M. Witte collaborates with scholars based in United States, United Kingdom and Germany. Michael M. Witte's co-authors include Robert C. Dickson, Paul Domanski, Oscar R. Colamonici, Paula M. Pitha, Paula T. Trzepacz, Menachem Rubinstein, John J. Krolewski, Hai Yan, Rebecca H. Hackett and Lewis V. Wray and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Michael M. Witte

45 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael M. Witte United States	22	537	440	413	412	193	45	1.5k
Hongyan Huang China	29	662 1.2×	385 0.9×	244 0.6×	571 1.4×	309 1.6×	95	2.1k
Vivian Goodell United States	20	470 0.9×	502 1.1×	108 0.3×	675 1.6×	99 0.5×	29	1.8k
Guang Chen China	23	955 1.8×	276 0.6×	346 0.8×	221 0.5×	130 0.7×	86	2.0k
Étienne Caron Canada	20	884 1.6×	325 0.7×	110 0.3×	646 1.6×	162 0.8×	46	1.6k
Jiye Zhu China	23	916 1.7×	559 1.3×	83 0.2×	421 1.0×	122 0.6×	111	2.4k
Ningping Feng United States	23	607 1.1×	521 1.2×	58 0.1×	451 1.1×	193 1.0×	65	1.7k
Sheema Hashem Qatar	19	998 1.9×	478 1.1×	99 0.2×	209 0.5×	59 0.3×	29	2.1k
Ru Yang China	27	700 1.3×	322 0.7×	77 0.2×	125 0.3×	177 0.9×	75	2.0k
Sangwon V. Kim United States	13	558 1.0×	148 0.3×	82 0.2×	797 1.9×	118 0.6×	29	2.0k
Jorma Palo Finland	23	524 1.0×	86 0.2×	194 0.5×	232 0.6×	299 1.5×	50	1.5k

Countries citing papers authored by Michael M. Witte

Since Specialization

Citations

This map shows the geographic impact of Michael M. Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Witte more than expected).

Fields of papers citing papers by Michael M. Witte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Witte. The network helps show where Michael M. Witte may publish in the future.

Co-authorship network of co-authors of Michael M. Witte

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Witte. A scholar is included among the top collaborators of Michael M. Witte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Witte. Michael M. Witte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Witte, Michael M., et al.. (2024). Characterizing the treatment patterns, medication burden, and patient demographics of older adults with major depressive disorder treated with antidepressants with or without selected comorbidities. Current Medical Research and Opinion. 40(6). 1027–1038. 1 indexed citations

Blauvelt, Andrew, Alexa B. Kimball, Matthias Augustin, et al.. (2022). Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1). British Journal of Dermatology. 187(6). 866–877. 29 indexed citations

Nair, Radhika, Virginia S. Haynes, Mir S. Siadaty, et al.. (2018). Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer’s disease in an administrative claims database. BMC Geriatrics. 18(1). 243–243. 22 indexed citations

Degenhardt, Elisabeth K., Michael M. Witte, Michael Case, et al.. (2016). Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia. IUScholarWorks (Indiana University). 2 indexed citations

Trzepacz, Paula T., Helen Hochstetler, Peng Yu, et al.. (2015). Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders. 41(1-2). 68–79. 11 indexed citations

Degenhardt, Elisabeth K., Michael M. Witte, Michael Case, et al.. (2015). Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia. Psychosomatics. 57(2). 208–216. 43 indexed citations

Degenhardt, Elisabeth K., Michael M. Witte, Michael Case, et al.. (2014). Florbetapir F18 PET Amyloid Neuroimaging and Baseline Characteristics in Patients with Alzheimer’s Dementia (P3.209). Neurology. 82(10_supplement). 1 indexed citations

Detke, Holland C., Fangyi Zhao, & Michael M. Witte. (2012). Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data. BMC Psychiatry. 12(1). 51–51. 11 indexed citations

Witte, Michael M., Michael Case, Kory Schuh, & Haya Ascher‐Svanum. (2012). Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia. Current Medical Research and Opinion. 28(3). 315–323. 18 indexed citations

10.

Fijal, Bonnie A., Virginia L. Stauffer, Bruce J. Kinon, et al.. (2011). Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone. The Journal of Clinical Psychiatry. 73(3). 367–371. 23 indexed citations

11.

Ascher‐Svanum, Haya, Xiaomei Peng, William Montgomery, et al.. (2010). Assessing the infrequent oral supplementation of olanzapine long-acting injection in the treatment of schizophrenia. European Psychiatry. 26(5). 313–319. 13 indexed citations

12.

Fijal, Bonnie A., Bruce J. Kinon, Shitij Kapur, et al.. (2009). Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia. The Pharmacogenomics Journal. 9(5). 311–318. 58 indexed citations

13.

Donnelly, Craig L., Mark E. Bangs, Paula T. Trzepacz, et al.. (2009). Safety and Tolerability of Atomoxetine Over 3 to 4 Years in Children and Adolescents With ADHD. Journal of the American Academy of Child & Adolescent Psychiatry. 48(2). 176–185. 48 indexed citations

14.

Gao, Sizhi Paul, Michael M. Witte, & Robert E. Scott. (2002). P2P‐R protein localizes to the nucleolus of interphase cells and the periphery of chromosomes in mitotic cells which show maximum P2P‐R immunoreactivity. Journal of Cellular Physiology. 191(2). 145–154. 26 indexed citations

15.

Witte, Michael M., et al.. (1998). Inhibition of Normal and Experimental Angiotumor Endothelial Cell Proliferation and Cell Cycle Progression by 2-Methoxyestradiol. Experimental Biology and Medicine. 219(3). 211–216. 39 indexed citations

16.

Domanski, Paul, et al.. (1995). Homodimerization and intermolecular tyrosine phosphorylation of the Tyk‐2 tyrosine kinase. FEBS Letters. 374(3). 317–322. 5 indexed citations

17.

Domanski, Paul, Michael M. Witte, Menachem Rubinstein, et al.. (1995). Cloning and Expression of a Long Form of the β Subunit of the Interferon αβ Receptor That Is Required for Signaling. Journal of Biological Chemistry. 270(37). 21606–21611. 215 indexed citations

18.

Scott, R E, et al.. (1993). Regulation of differentiation, proliferation and cancer suppressor activity. The International Journal of Developmental Biology. 37(1). 67–74. 10 indexed citations

19.

Witte, Michael M. & Robert C. Dickson. (1988). Cysteine Residues in the Zinc Finger and Amino Acids Adjacent to the Finger Are Necessary for DNA Binding by the LAC9 Regulatory Protein of Kluyveromyces lactis. Molecular and Cellular Biology. 8(9). 3726–3733. 12 indexed citations

20.

Behne, D., et al.. (1976). Effects of sex hormones and of pregnancy on the selenium metabolism. Bioinorganic Chemistry. 5(3). 199–202. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact